These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24667938)

  • 1. Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugs.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Gvetadze RJ; Kittimunkong S; Curlin ME; Worrajittanon D; McNicholl JM; Paxton LA; Choopanya K;
    PLoS One; 2014; 9(3):e92809. PubMed ID: 24667938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
    Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Chuachoowong R; Mock PA; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; van Griensven F; McNicholl JM; Paxton L; Choopanya K;
    PLoS One; 2011; 6(9):e25127. PubMed ID: 21969870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
    Choopanya K; Martin M; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Kitisin P; Natrujirote P; Kittimunkong S; Chuachoowong R; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Hendrix CW; Vanichseni S;
    Lancet; 2013 Jun; 381(9883):2083-90. PubMed ID: 23769234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
    Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012.
    Vanichseni S; Martin M; Suntharasamai P; Sangkum U; Mock PA; Gvetadze RJ; Curlin ME; Leethochawalit M; Chiamwongpaet S; Chaipung B; McNicholl JM; Paxton LA; Kittimunkong S; Choopanya K
    Am J Public Health; 2015 Jun; 105(6):1136-41. PubMed ID: 25880964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.
    Liu AY; Vittinghoff E; Chillag K; Mayer K; Thompson M; Grohskopf L; Colfax G; Pathak S; Gvetadze R; Oʼhara B; Collins B; Ackers M; Paxton L; Buchbinder SP
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):87-94. PubMed ID: 23481668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Curlin ME; Na-Pompet S; Warapronmongkholkul A; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Choopanya K;
    AIDS; 2015 Apr; 29(7):819-24. PubMed ID: 25985403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The finding of casual sex partners on the internet, methamphetamine use for sexual pleasure, and incidence of HIV infection among men who have sex with men in Bangkok, Thailand: an observational cohort study.
    Piyaraj P; van Griensven F; Holtz TH; Mock PA; Varangrat A; Wimonsate W; Thienkrua W; Tongtoyai J; McNamara A; Chonwattana W; Nelson KE
    Lancet HIV; 2018 Jul; 5(7):e379-e389. PubMed ID: 29861202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ogbuagu O; Ruane PJ; Podzamczer D; Salazar LC; Henry K; Asmuth DM; Wohl D; Gilson R; Shao Y; Ebrahimi R; Cox S; Kintu A; Carter C; Das M; Baeten JM; Brainard DM; Whitlock G; Brunetta JM; Kronborg G; Spinner CD;
    Lancet HIV; 2021 Jul; 8(7):e397-e407. PubMed ID: 34197772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
    Matthews LT; Heffron R; Mugo NR; Cohen CR; Hendrix CW; Celum C; Bangsberg DR; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):91-7. PubMed ID: 25118795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
    AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.
    Kitayaporn D; Vanichseni S; Mastro TD; Raktham S; Vaniyapongs T; Des Jarlais DC; Wasi C; Young NL; Sujarita S; Heyward WL; Esparza J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):289-95. PubMed ID: 9803972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study.
    Buavirat A; Page-Shafer K; van Griensven GJ; Mandel JS; Evans J; Chuaratanaphong J; Chiamwongpat S; Sacks R; Moss A
    BMJ; 2003 Feb; 326(7384):308. PubMed ID: 12574043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.
    Grohskopf LA; Chillag KL; Gvetadze R; Liu AY; Thompson M; Mayer KH; Collins BM; Pathak SR; Oʼhara B; Ackers ML; Rose CE; Grant RM; Paxton LA; Buchbinder SP
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):79-86. PubMed ID: 23466649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
    PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
    AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
    Marcus JL; Glidden DV; Mayer KH; Liu AY; Buchbinder SP; Amico KR; McMahan V; Kallas EG; Montoya-Herrera O; Pilotto J; Grant RM
    PLoS One; 2013; 8(12):e81997. PubMed ID: 24367497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
    Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B
    AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.